{{Rsnum
|rsid=1821777
|Gene=IRAK3
|Chromosome=12
|position=66212448
|Orientation=plus
|GMAF=0.219
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=IRAK3
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 41.6 | 46.0 | 12.4
| HCB | 70.8 | 27.7 | 1.5
| JPT | 75.2 | 23.0 | 1.8
| YRI | 70.5 | 27.4 | 2.1
| ASW | 64.9 | 35.1 | 0.0
| CHB | 70.8 | 27.7 | 1.5
| CHD | 74.3 | 22.0 | 3.7
| GIH | 65.3 | 31.7 | 3.0
| LWK | 70.0 | 25.5 | 4.5
| MEX | 71.9 | 24.6 | 3.5
| MKK | 67.1 | 30.3 | 2.6
| TSI | 44.1 | 48.0 | 7.8
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs1821777
|Name_s=
|Gene_s=IRAK3
|Feature=
|Evidence=PubMed ID:17503328
|Annotation=rs1821777 was found by transmission/disequilibrium test and case-control analysis of families from Sardinia and mainland Italy to be associated with susceptibility to Early-Onset Persistent Asthma.
|Drugs=
|Drug Classes=
|Diseases=Asthma
|Curation Level=Curated
|PharmGKB Accession ID=PA162191380
}}

{{PMID Auto
|PMID=19264973
|Title=Assessing the reproducibility of asthma candidate gene associations, using genome-wide data.
|OA=1
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1821777
|overall_frequency_n=23
|overall_frequency_d=128
|overall_frequency=0.179688
|n_genomes=20
|n_genomes_annotated=0
|n_haplomes=23
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}